Advertisement

CEN Case Reports

, Volume 7, Issue 2, pp 313–315 | Cite as

Paraplegia as a presentation of primary hyperoxaluria

  • Yannick Dieudonné
  • Laure Eprinchard
  • Emilie Léon
  • Pierre Oswald
  • Anne Gressel
  • Sophie Carre
  • Yves Dimitrov
Case Report
  • 30 Downloads

Abstract

30% of the patients suffering from hyperoxaluria type 1 are diagnosed only when they already had reached end-stage renal disease. We report the case of a 57-year-old woman with history of chronic kidney failure presenting with paraplegia due to spinal cord compression by thoracic mass-like lesions. Bone biopsy specimen obtained by decompressive laminectomy revealed calcium oxalate deposits. Once diagnosis of primary hyperoxaluria was confirmed, she underwent haemodialysis with incomplete improvement of her neurological disorders and was registered on the waiting list for transplantation.

Keywords

Hyperoxaluria End-stage renal disease Nephrocalcinosis Oxalosis Paraplegia 

Notes

Compliance with ethical standards

Conflict of interest

The authors have declared that no conflict of interest exists.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Written informed consent was obtained from the patient’s parents for publication of this case report and accompanying images. A copy of the written consent may be requested for review from the corresponding author.

References

  1. 1.
    Worcester EM, Coe FL. Calcium kidney stones. N Engl J Med. 2010;363:954–63.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Cochat P. Primary hyperoxaluria type 1. Kidney Int. 1999;55:2533–47.CrossRefPubMedGoogle Scholar
  3. 3.
    Bacchetta J, Boivin G, Cochat P. Bone Impairment in primary hyperoxaluria: a review. Pediatr Nephrol. 2016;31:1–6.CrossRefPubMedGoogle Scholar
  4. 4.
    Mulay SR, Kulkarni OP, Rupanagudi KV, Migliorini A, Darisipudi MN, Vilaysane A, Muruve D, Shi Y, Munro F, Liapis H, Anders HJ. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion. J Clin Invest. 2013;12:236–46.CrossRefGoogle Scholar
  5. 5.
    Cochat P, Rumsby G. Primary hyperoxaluria. N Engl J Med. 2013;369:649–58.CrossRefPubMedGoogle Scholar
  6. 6.
    Hoppe B. An update on primary hyperoxaluria. Nat Rev Nephrol. 2012;8:467–75.CrossRefPubMedGoogle Scholar
  7. 7.
    Hoppe B, Beck BB, Milliner DS. The primary hyperoxalurias. Kidney Int. 2009;75:1264–71.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Tang X, Bergstralh EJ, Mehta RA, Vrtiska TJ, Milliner DS, Lieske JC. Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria. Kidney Int. 2015;87:623–31.CrossRefPubMedGoogle Scholar
  9. 9.
    Nair P, Al-Otaibi T, Nampoory N, Al-Qabandi W, Said T, Halim MA, Gheith O. Combined liver and kidney transplantation in primary hyperoxaluria: a report of three cases and review of the literature. Saudi J Kidney Dis Transpl. 2013;24:969–75.CrossRefPubMedGoogle Scholar
  10. 10.
    Bhasin B, Ürekli HM, Atta MG. Primary and secondary hyperoxaluria: understanding the enigma. World J Nephrol. 2015;4:235–44.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2018

Authors and Affiliations

  1. 1.Nephrology DepartmentCH HaguenauHaguenauFrance
  2. 2.Radiology DepartmentCH HaguenauHaguenauFrance
  3. 3.Pathology DepartmentCHU StrasbourgStrasbourgFrance
  4. 4.Neurology DepartmentCH HaguenauHaguenauFrance

Personalised recommendations